Status:
NOT_YET_RECRUITING
Surgical and Pharmacological Efficacy of Knosp Grade 0-2 Prolactinoma
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University
Collaborating Sponsors:
Peking Union Medical College Hospital
West China Hospital
Conditions:
Pituitary Tumor
Eligibility:
All Genders
20-40 years
Phase:
NA
Brief Summary
The investigators carried out a multi-center comparative study, involving hospitals including the Second Affiliated Hospital of Zhejiang University School of Medicine, Peking Union Medical College Hos...
Eligibility Criteria
Inclusion
- Prolactin level greater than three times the normal upper limit
- MRI indicates Knosp Grade 0-2 pituitary adenoma
Exclusion
- MRI indicates Knosp grade 3-4 pituitary adenoma
- Taking antidepressants or other psychotropic drugs
- Patients allergic to bromocriptine or cannot tolerate surgery
- Women defined as surgical infertility (i.e. hysterectomy, bilateral salpingectomy, or bilateral oophorectomy), or amenorrhea for more than 2 years
- Critical illness patients, such as those with progressive consciousness disorders, cerebral hernias, and other emergency situations
Key Trial Info
Start Date :
October 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2027
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT06556186
Start Date
October 1 2024
End Date
March 31 2027
Last Update
August 15 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.